Menu
GWAS Study

Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.

Hüffmeier U, Uebe S, Ekici AB et al.

20953186 PubMed ID
GWAS Study Type
6948 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HU
Hüffmeier U
US
Uebe S
EA
Ekici AB
BJ
Bowes J
GE
Giardina E
KE
Korendowych E
JK
Juneblad K
AM
Apel M
MR
McManus R
HP
Ho P
BI
Bruce IN
RA
Ryan AW
BF
Behrens F
LJ
Lascorz J
BB
Böhm B
TH
Traupe H
LJ
Lohmann J
GC
Gieger C
WH
Wichmann HE
HC
Herold C
SM
Steffens M
KL
Klareskog L
WT
Wienker TF
FO
Fitzgerald O
AG
Alenius GM
MN
McHugh NJ
NG
Novelli G
BH
Burkhardt H
BA
Barton A
RA
Reis A
Chapter II

Abstract

Summary of the research findings

Psoriatic arthritis (PsA) is an inflammatory joint disease that is distinct from other chronic arthritides and which is frequently accompanied by psoriasis vulgaris (PsV) and seronegativity for rheumatoid factor. We conducted a genome-wide association study in 609 German individuals with PsA (cases) and 990 controls with replication in 6 European cohorts including a total of 5,488 individuals. We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 × 10⁻¹⁷). TRAF3IP2 was also associated with PsV in a German cohort including 2,040 individuals (rs13190932, P = 1.95 × 10⁻³). Sequencing of the exons of TRAF3IP2 identified a coding variant (p.Asp10Asn, rs33980500) as the most significantly associated SNP (P = 1.13 × 10⁻²⁰, odds ratio = 1.95). Functional assays showed reduced binding of this TRAF3IP2 variant to TRAF6, suggesting altered modulation of immunoregulatory signals through altered TRAF interactions as a new and shared pathway for PsA and PsV.

572 European ancestry cases, 888 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

6948
Total Participants
GWAS
Study Type
Yes
Replicated
Up to 1,761 European ancestry cases, 3,727 European ancestry controls
Replication Participants
European
Ancestry
Germany, Sweden, Italy, U.K., Republic of Ireland
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.